A Philadelphia founder has been using artificial intelligence for life sciences materials since 2015, long before the mainstream hype for the tech.

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

The purpose of the incorporation of this wholly owned subsidiary is to expand the biopharma products business in Europe.

GIC Re on Monday posted a 17% decline in net profit to ₹2,183 crore for the fourth quarter ended March 2025. The state-owned ...